<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05047393</url>
  </required_header>
  <id_info>
    <org_study_id>2021-06/21</org_study_id>
    <nct_id>NCT05047393</nct_id>
  </id_info>
  <brief_title>Vitamin D Level and Pain Type in Coccygodynia</brief_title>
  <official_title>Effect of Vitamin D Level on Pain Type in Coccygodynia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sivas Cumhuriyet University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sivas Cumhuriyet University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Coccygodynia is a painful clinical picture of the sacrococcygeal region.Pain in coccygodynia&#xD;
      may be somatic, neuropathic or mixed. There are many studies that emphasize the relationship&#xD;
      between vitamin D deficiency and pain.In this study, it is aimed to investigate the severity&#xD;
      and type of pain, as well as the effect of vitamin D level on pain in patients with&#xD;
      coccygodynia&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There are different types of pain in coccygodynia. Patients may suffer from e somatic,&#xD;
      neuropathic or mixed pain.Vitamin D plays an important role in the pathophysiology of pain.&#xD;
      Vitamin D inhibits NO synthase (iNOS) in microglia and astrocytes. The importance of this is&#xD;
      that nitric oxide (NO) is an important molecule in the development of neuropathic pain. NO&#xD;
      production contributes to the maintenance of pain hypersensitivity. NO causes central&#xD;
      sensitization and mechanical allodynia by increasing spinal cord posterior horn&#xD;
      N-methyl-D-aspartate (NMDA) receptors.In the literature, it has been reported that low&#xD;
      vitamin D level is associated with the severity of neuropathic pain in postherpetic&#xD;
      neuralgia, diabetic neuropathy, rheumatoid arthritis and carpal tunnel syndrome, which cause&#xD;
      neuropathic pain development.&#xD;
&#xD;
      Based on the above-mentioned data, in this study, I aimed to investigate the severity and&#xD;
      type of pain, as well as the effect of vitamin D level on pain in patients with coccygodynia.&#xD;
      Within the scope of the study, 51 patients with a diagnosis of coccygodynia will be&#xD;
      recruited. Patients' age, gender, body mass index, duration of symptoms, etiology of&#xD;
      coccycodynia, pain severity, pain type and blood vitamin D level will be recorded. Pain&#xD;
      assessment (for discrimination between nociceptive, mixed and neuropathic pain) will be done&#xD;
      with the painDETECT questionairre. Pain severity will be evaluated with Visual Analog Scale&#xD;
      (VAS). Those with vitamin D levels &lt; 20 ng/mL, 20-30 ng/mL, and ˃30 ng/mL will be grouped as&#xD;
      deficiency, insufficiency and normal, respectively.The data will be entered into the SPSS&#xD;
      (version: 22.0) IBM SPSS statistical package program. Arithmetic mean, standard deviation,&#xD;
      min-max, median values will be given in the data obtained by measurement. Percentage and&#xD;
      frequency distribution will be given in the data obtained by counting. In statistical&#xD;
      evaluations, parametric tests will be used for normally distributed data, and non-parametric&#xD;
      tests will be used for data not normally distributed. Relationships will be compared&#xD;
      according to the Pearson or Spearman correlation coefficient. Chi-square test will be applied&#xD;
      to categorical data. P&lt;0.05 will be considered significant.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2021</start_date>
  <completion_date type="Anticipated">February 28, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>Neuropathic pain in coccygodynia</measure>
    <time_frame>The study will be completed in 7 months.</time_frame>
    <description>PainDETECT neuropathic pain questionnaire will be used to evaluate the presence of neuropathic pain in patients.The questionnaire score ranges from 0-35 points, and a score of 19 and above indicates the presence of neuropathic pain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vitamin D level in coccygodynia</measure>
    <time_frame>The study will be completed in 7 months.</time_frame>
    <description>Vitamin D level of the patients registered in the hospital system will be recorded.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">51</enrollment>
  <condition>Coccyx Disorder</condition>
  <condition>Neuropathic Pain</condition>
  <condition>Nociceptive Pain</condition>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>Coccygodynia group</arm_group_label>
    <description>51 patients with a diagnosis of coccygodynia will be included in the study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Current blood vitamin D level and painDetect questionairre score will be detected</intervention_name>
    <description>PainDETECT neuropathic pain questionnaire will be used to evaluate the presence of nociceptive, mixed and neuropathic pain in patients. Patients with a total questionnaire score of 12 or less are considered nociceptive pain without a neuropathic pain component. If the total score is in the range of 13-18, the result is uncertain, but it is accepted that the neuropathic component can be found in the mixed type, and in the scores of 19 and above, it is accepted that the neuropathic pain component is present. Patients with previously obtained and finalized vitamin D levels &lt; 20 ng/mL, 20-30 ng/mL, and ˃30 ng/mL will be grouped as deficiency, insufficiency and normal, respectively.</description>
    <arm_group_label>Coccygodynia group</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Venous blood samples will be obtained from the patients. Vitamin D level will be determined&#xD;
      from blood samples.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who applied to Sivas Cumhuriyet University Faculty of Medicine Physical Therapy&#xD;
        and Rehabilitation clinic between 01/08/2021 and 28/02/2022 and were diagnosed with&#xD;
        coccygodynia and had their vitamin D levels checked will be included in the study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosed with coccygodynia&#xD;
&#xD;
          -  18-70 years old&#xD;
&#xD;
          -  Having a vitamin D level determined&#xD;
&#xD;
          -  Agreement to take part in the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Presence of known polyneuropathy,&#xD;
&#xD;
          -  Presence of diabetes mellitus, renal failure, thyroid diseases&#xD;
&#xD;
          -  Taking vitamin D replacement therapy,&#xD;
&#xD;
          -  Using any of the medications used in the treatment of neuropathic pain such as&#xD;
             duloxetine, pregabalin, gabapentin and tramadol, Having undergone an interventional&#xD;
             procedure for coccygodynia within 3 months before the evaluation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emel Güler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sivas Cumhuriyet University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emel Güler, MD</last_name>
    <phone>+905356492951</phone>
    <email>dremelguler@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hanzade Ünal-Artık, MD</last_name>
    <phone>+905057179039</phone>
    <email>hanzadeunal@windowslive.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Emel Guler</name>
      <address>
        <city>Sivas</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>emel guler</last_name>
      <phone>+905356492951</phone>
      <email>emelguler@cumhuriyet.edu.tr</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/28857474/</url>
    <description>Association between serum vitamin D levels and neuropathic pain in rheumatoid arthritis</description>
  </link>
  <reference>
    <citation>Yesil H, Sungur U, Akdeniz S, Gurer G, Yalcın B, Dundar U. Association between serum vitamin D levels and neuropathic pain in rheumatoid arthritis patients: A cross-sectional study. Int J Rheum Dis. 2018 Feb;21(2):431-439. doi: 10.1111/1756-185X.13160. Epub 2017 Aug 31.</citation>
    <PMID>28857474</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>August 31, 2021</study_first_submitted>
  <study_first_submitted_qc>September 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 17, 2021</study_first_posted>
  <last_update_submitted>September 21, 2021</last_update_submitted>
  <last_update_submitted_qc>September 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sivas Cumhuriyet University</investigator_affiliation>
    <investigator_full_name>Emel Güler</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Coccyx</keyword>
  <keyword>Nociceptive Pain</keyword>
  <keyword>Neuropathic Pain</keyword>
  <keyword>Chronic pain</keyword>
  <keyword>Vitamin D Deficiency</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuralgia</mesh_term>
    <mesh_term>Vitamin D Deficiency</mesh_term>
    <mesh_term>Nociceptive Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

